Short answer
Guardian Pharmacy Services, Inc. (GRDN) filed its Q1 2026 10-Q quarterly report on May 6, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $337M (up 2.2% year over year) with net income of $13M.
Q1 2026 key financials · XBRL
- Revenue
- $337M
- +2.2% YoY
- Net income
- $13M
- +40.7% YoY
- Operating margin
- 5.3%
- Gross margin
- 22.7%
Source: XBRL data from the Guardian Pharmacy Services, Inc. (GRDN) Q1 2026 10-Q on SEC EDGAR. USD.
Guardian Pharmacy Services, Inc. Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $336.6M, up 2.2% YoY from $329.3M; organic revenue decreased $11.2M amid IRA pricing changes
- Net margin 4.0% vs 2.8%; Adjusted EBITDA margin 8.8% vs 7.1% YoY
- Residents served increased to 207,000 from 189,000; prescriptions dispensed rose to 7.4M from 6.7M
- Cash $64.9M; operating cash flow $6.1M vs $17.6M YoY
- IRA pricing reductions and working-capital timing pressured revenue and operating cash flow; $8.5M settlement cash received April 21, 2026
Risk Factors
- No material changes to risk factors from the December 31, 2025 Form 10-K
- Investment risk: adverse developments could materially affect business, financial condition, results, and prospects
- Equity-market risk: Class A common stock price could decline, causing partial or total investment loss
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Guardian Pharmacy Services, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.